March 23, 2011
 
Boehringer Ingelheim's pig vaccine is approved in Europe

Boehringer Ingelheim's new label claim for pig vaccine, Ingelvac MycoFLEX, is permitted to be mixed with the world leading PCV-2 vaccine, Ingelvac CircoFLEX, after its approval in Europe.

The label variation for Ingelvac MycoFLEX completes a process in which Ingelvac CircoFLEX had received a corresponding mixing claim by the European Commission in July 2010.

Boehringer Ingelheim is marketing the unique flexible concept of combinable stand alone vaccines against PCV2/Mycoplasma hyopneumoniae under the name FLEXcombo.

Mixing of Ingelvac CircoFLEX and Ingelvac MycoFLEX allows pigs to be protected against two of the most prominent and costly diseases more conveniently than in the past as it uses one injection instead of up to four injections. This provides several benefits in animal welfare (less stress for pigs), farm economics (saving labour) and animal health (fewer chances for pathogen transfer via injection needles).